Condensed Statement of Cash Flows (Unaudited)	3 Months Ended
	Sep. 30, 2020 USD ($)
Cash Flows from Operating Activities:
Net loss	$ (56,923)
Adjustments to reconcile net loss to net cash used in operating activities:
Interest earned on marketable securities held in trust account	(2,790)
Changes in operating assets and liabilities:
Prepaid expenses	(325,442)
Accrued expenses	19,347
Net cash used in operating activities	(365,808)
Cash Flows from Investing Activities:
Investment of cash into Trust Account	(442,750,000)
Net cash used in investing activities	(442,750,000)
Cash Flows from Financing Activities:
Proceeds from sale of Units, net of underwriting discounts paid	433,895,000
Proceeds from sale of Private Placement Warrants	10,855,000
Proceeds from promissory note – related party	112,837
Repayment of promissory note – related party	(165,081)
Payment of offering costs	(441,969)
Net cash provided by financing activities	444,255,787
Net Change in Cash	1,139,979
Cash – Beginning of period
Cash – End of period	1,139,979
Non-Cash financing activities:
Initial classification of common stock subject to possible redemption	423,731,850
Change in value of common stock subject to possible redemption	(54,240)
Deferred underwriting fee payable	15,496,250
Offering costs paid directly by Sponsor in consideration for the issuance of Class B common stock	25,000
Deferred offering costs included in accrued offering costs	25,000
Payment of offering costs through promissory note — related party	$ 52,244